Cancer Family
Bone Marrow Neoplasm
CI-CAN-00000093Explore in graph →
Non-malignant1,034 active trials28 approved drugs633 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000093Explore in graph →
Clinical trials
4,612 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02435550 | iCare for Cancer Patients | terminated | N/A | 136 | University of FloridaOTHER | 1 | Dec 20, 2019 | clinicaltrials |
| NCT00001623 | Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | completed | N/A | 41 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT04168138 |
| D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients |
| unknown |
| N/A |
| 20 |
| Huihan WangOTHER |
| 1 |
| Nov 19, 2019 |
| clinicaltrials |
| NCT02719821 | Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation | completed | N/A | 17 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02955043 | Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery | completed | N/A | 39 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00856388 | Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders | completed | N/A | 62 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT03442452 | AML Electronic Decision Aid | completed | N/A | 20 | Duke UniversityOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT00005799 | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | N/A | 55 | Fred Hutchinson Cancer CenterOTHER | 2 | Sep 10, 2019 | clinicaltrials |
| NCT00179764 | Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) | completed | N/A | 68 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01519596 | Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy | completed | N/A | 70 | Wake Forest University Health SciencesOTHER | 1 | Aug 16, 2019 | clinicaltrials |
| NCT02360111 | GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2019 | clinicaltrials |
| NCT03062436 | To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission | unknown | N/A | 27 | Command Hospital, IndiaOTHER_GOV | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02602587 | Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients(OXYLAM) | completed | N/A | 37 | University Hospital, ToulouseOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT03902769 | Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.(AML) | unknown | N/A | 160 | Rambam Health Care CampusOTHER | 0 | Apr 8, 2019 | clinicaltrials |
| NCT01499147 | Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies | completed | N/A | 100 | University of Illinois at ChicagoOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03726944 | The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients | completed | N/A | 128 | Arizona State UniversityOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT00038870 | Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 25, 2018 | clinicaltrials |
| NCT00789256 | Low Dose Melphalan and Bortezomib for AML and High-Risk MDS | completed | N/A | 26 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT02877277 | Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study(EVITA-Pilot) | completed | N/A | 20 | Rigshospitalet, DenmarkOTHER | 1 | Sep 24, 2018 | clinicaltrials |
| NCT00453206 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases | completed | N/A | 66 | Wake Forest University Health SciencesOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT01490775 | Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy | terminated | N/A | 27 | Rex Cancer Center, Raleigh, NCOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT01490983 | Telemonitoring Study - for Chronic Myeloid Leukemia (CML) | terminated | N/A | 14 | Rex Cancer Center, Raleigh, NCOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT01598025 | Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor | terminated | N/A | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT03086252 | Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study | withdrawn | N/A | 0 | Emory UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT01872819 | Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay | completed | N/A | 16 | University of WashingtonOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01053494 | Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer | completed | N/A | 80 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02101983 | Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) | completed | N/A | 11 | University of RochesterOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT01804101 | Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia | completed | N/A | 48 | Fred Hutchinson Cancer CenterOTHER | 1 | May 25, 2018 | clinicaltrials |
| NCT02121418 | Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm | completed | N/A | 12 | University of WashingtonOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT02519712 | Treatment of Elderly AML Patients With Induction Chemotherapy Followed by G-CSF-Mobilized Stem Cells From Haploidentical Related Donors | terminated | N/A | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT01779882 | Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT | completed | N/A | 72 | University Hospital, Basel, SwitzerlandOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT03408210 | Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia | unknown | N/A | 191 | Affiliated Hospital to Academy of Military Medical SciencesOTHER | 1 | Jan 23, 2018 | clinicaltrials |
| NCT00445744 | Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome | completed | N/A | 52 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 2, 2018 | clinicaltrials |
| NCT02676856 | Hematopoietic Stem Cell Microtransplantation for in AML | unknown | N/A | 40 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT00167167 | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | completed | N/A | 40 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00290628 | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | terminated | N/A | 43 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00290641 | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | completed | N/A | 68 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT01831232 | Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes | completed | N/A | 24 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03337516 | Interest of a Therapeutic Follow-up of the Cytarabine in the Acute Myeloid Leukaemia: Is There Constitutional Biomarkers | unknown | N/A | 40 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Nov 9, 2017 | clinicaltrials |
| NCT03280290 | Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft(CCR7-CD4-DPL) | completed | N/A | 20 | University Hospital, LilleOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT01076270 | Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | terminated | N/A | 1 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 28, 2017 | clinicaltrials |
| NCT02099266 | Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT03177928 | Cardiac Changes in Myeloproliferative Neoplasms | unknown | N/A | 40 | Assiut UniversityOTHER | 0 | Jun 6, 2017 | clinicaltrials |
| NCT00376922 | Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases | completed | N/A | 65 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00112593 | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer | completed | N/A | 5 | Fred Hutchinson Cancer CenterOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT02160600 | Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial | completed | N/A | 124 | All India Institute of Medical SciencesOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT00363467 | Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation | terminated | N/A | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00408681 | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant(GVHD) | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT02863302 | Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients | unknown | N/A | 50 | Rambam Health Care CampusOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT00726934 | The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients | completed | N/A | 149 | Indiana UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Dec 20, 2019source: clinicaltrials